28-Mar-2024
Globe Newswire (Thu, 28-Mar 8:15 AM ET)
Emergent BioSolutions receives NAI status for Baltimore Bayview manufacturing facility
Seeking Alpha News (Mon, 25-Mar 8:54 AM ET)
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
Globe Newswire (Mon, 25-Mar 8:05 AM ET)
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
Globe Newswire (Wed, 6-Mar 4:31 PM ET)
Globe Newswire (Thu, 29-Feb 7:00 AM ET)
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
Globe Newswire (Wed, 21-Feb 7:00 AM ET)
Globe Newswire (Thu, 11-Jan 8:00 AM ET)
Globe Newswire (Tue, 9-Jan 7:30 AM ET)
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Emergent Biosolutions trades on the NYSE stock market under the symbol EBS.
As of March 28, 2024, EBS stock price declined to $2.53 with 1,018,381 million shares trading.
EBS has a beta of 2.87, meaning it tends to be more sensitive to market movements. EBS has a correlation of 0.11 to the broad based SPY ETF.
EBS has a market cap of $131.27 million. This is considered a Micro Cap stock.
Last quarter Emergent Biosolutions reported $277 million in Revenue and -$.77 earnings per share. This fell short of revenue expectation by $-17 million and missed earnings estimates by -$.58.
In the last 3 years, EBS stock traded as high as $94.89 and as low as $1.42.
The top ETF exchange traded funds that EBS belongs to (by Net Assets): FNDA, VTI, IWM, VXF, PRFZ.
EBS has underperformed the market in the last year with a return of -71.4%, while the SPY ETF gained +33.6%. In the last 3 month period, EBS fell short of the market, returning +5.4%, while SPY returned +10.1%. However, in the most recent 2 weeks EBS has outperformed the stock market by returning +12.9%, while SPY returned +1.7%.
EBS support price is $2.42 and resistance is $2.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EBS stock will trade within this expected range on the day.